Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor
Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001
In Reply: We agree with Dr Bates that treating as many eligible patients as possible with timely reperfusion therapy is important. We found that only 71% of eligible patients with acute myocardial infarction received reperfusion therapy and recommended that efforts "be made to increase reperfusion rates for eligible patients."1 However, we would like to address 3 other points.
Magid DJ, Calonge BN, Rumsfield JS. Outcomes of Angioplasty vs Thrombolysis by Hospital Angioplasty Volume—Reply. JAMA. 2001;285(13):1701-1702. doi:10.1001/jama.285.13.1701